201 related articles for article (PubMed ID: 27009849)
1. Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people.
Ching LK; Gounder PP; Bulkow L; Spradling PR; Bruce MG; Negus S; Snowball M; McMahon BJ
Liver Int; 2016 Oct; 36(10):1507-15. PubMed ID: 27009849
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis.
Gounder PP; Bulkow LR; Snowball M; Negus S; Spradling PR; McMahon BJ
J Pediatr; 2016 Nov; 178():206-213. PubMed ID: 27590612
[TBL] [Abstract][Full Text] [Related]
3. HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study.
McMahon BJ; Nolen LD; Snowball M; Homan C; Negus S; Roik E; Spradling PR; Bruden D
Hepatology; 2021 Dec; 74(6):2965-2973. PubMed ID: 34292609
[TBL] [Abstract][Full Text] [Related]
4. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
Livingston SE; Simonetti JP; Bulkow LR; Homan CE; Snowball MM; Cagle HH; Negus SE; McMahon BJ
Gastroenterology; 2007 Nov; 133(5):1452-7. PubMed ID: 17920063
[TBL] [Abstract][Full Text] [Related]
5. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.
Pollack HJ; Kwon SC; Wang SH; Wyatt LC; Trinh-Shevrin C;
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2229-39. PubMed ID: 25368398
[TBL] [Abstract][Full Text] [Related]
7. Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Gounder PP; Bulkow LR; Snowball M; Negus S; Spradling PR; Simons BC; McMahon BJ
Aliment Pharmacol Ther; 2016 Jun; 43(11):1197-207. PubMed ID: 27061300
[TBL] [Abstract][Full Text] [Related]
8. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
9. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
[TBL] [Abstract][Full Text] [Related]
10. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
11. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
12. Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.
Tohme RA; Bulkow L; Homan CE; Negus S; McMahon BJ
J Clin Virol; 2013 Oct; 58(2):396-400. PubMed ID: 24001884
[TBL] [Abstract][Full Text] [Related]
13. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.
McMahon BJ; Holck P; Bulkow L; Snowball M
Ann Intern Med; 2001 Nov; 135(9):759-68. PubMed ID: 11694101
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of hepatitis B virus genotypes and its clinical significance in Guangxi].
Ge XM; Li DY; Fang ZL; Huang GY; Jiang SQ; Pan HD; Du Y; Wang CY; Ding X; Masashi M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):174-9. PubMed ID: 12870004
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
[TBL] [Abstract][Full Text] [Related]
16. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
[TBL] [Abstract][Full Text] [Related]
17. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
[TBL] [Abstract][Full Text] [Related]
18. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
19. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
20. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
